Covered recipient · General Payments record
MELISSA S DOBBINS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,581.42
- Reported across 198 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $403.79 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $143.90 | 9 |
| Amgen Inc. | $136.90 | 10 |
| Novo Nordisk AS | $33.17 | 2 |
| Astellas Pharma US Inc | $30.41 | 2 |
| Otsuka America Pharmaceutical, Inc. | $29.96 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.23 | 1 |
| Lilly USA, LLC | $13.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.72 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647492 | CMS |
| ABBVIE INC. | $16.24 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647494 | CMS |
| ABBVIE INC. | $18.40 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647496 | CMS |
| ABBVIE INC. | $6.76 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647498 | CMS |
| ABBVIE INC. | $34.65 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647500 | CMS |
| ABBVIE INC. | $9.74 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647502 | CMS |
| ABBVIE INC. | $14.61 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647504 | CMS |
| ABBVIE INC. | $11.27 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647506 | CMS |
| ABBVIE INC. | $14.51 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103647508 | CMS |
| Amgen Inc. | $12.83 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115579529 | CMS |
| Amgen Inc. | $12.65 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115579585 | CMS |
| Amgen Inc. | $11.59 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115579537 | CMS |
| Amgen Inc. | $14.70 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115579553 | CMS |
| Amgen Inc. | $13.39 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240172 | CMS |
| Amgen Inc. | $16.22 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115579561 | CMS |
| Amgen Inc. | $20.79 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240174 | CMS |
| Amgen Inc. | $11.56 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115579570 | CMS |
| Amgen Inc. | $11.16 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240176 | CMS |
| Amgen Inc. | $12.01 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115579577 | CMS |
| Astellas Pharma US Inc | $17.03 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139271580 | CMS |
| Astellas Pharma US Inc | $13.38 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139398611 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.23 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086222074 | CMS |
| Lilly USA, LLC | $13.22 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135199727 | CMS |
| Novo Nordisk Inc | $17.12 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096897394 | CMS |
| Novo Nordisk Inc | $16.05 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096752153 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.77 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118885833 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.19 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118885835 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.